老年院内心搏骤停后的生存与神经功能结局
该大型观察性研究纳入2007—2015年瑞典心肺复苏登记中≥70岁的院内心搏骤停患者共11396例,按年龄分为70—79岁、80—89岁、≥90岁三组,分析30天生存率及神经功能结局。30天生存率分别为28%、20%和14%;初始可电击心律、心电图监测地点发生、目击、白天(8 a.m.—8 p.m.)发生及心律失常病因与较高生存率相关,心力衰竭、呼吸功能不全、肾功能不全及急性肺水肿病因与较低生存率相关。≥90岁且初始心律为VF/VT者生存率达41%。存活者中年龄与良好神经功能结局(CPC 1—2)无显著关联,三组分别为92%、93%和88%。
要点
- ≥70岁院内心搏骤停患者30天生存率随年龄增加而降低:70—79岁28%、80—89岁20%、≥90岁14%(瑞典心肺复苏登记2007—2015年,11396例)。
- ≥90岁且初始心律为VF/VT的院内心搏骤停患者生存率达41%,提示该亚组不应仅凭年龄放弃复苏。
- 初始可电击心律、心电图监测地点发生、目击、白天(8 a.m.—8 p.m.)发生及心律失常病因与较高生存率相关。
- 心力衰竭病史、呼吸功能不全、肾功能不全及急性肺水肿病因与较低生存率相关。
- 存活者中年龄与良好神经功能结局(CPC 1—2)无显著关联:70—79岁92%、80—89岁93%、≥90岁88%。
适用人群与场景
- ≥70岁院内心搏骤停患者,登记于瑞典心肺复苏登记2007—2015年。
- 按年龄分为70—79岁、80—89岁和≥90岁三组进行描述性分析。
研究设计与关键结果
- 研究类型为大型观察性研究,纳入11396例≥70岁院内心搏骤停患者,数据来自瑞典心肺复苏登记2007—2015年。
- 30天生存率:70—79岁28%,80—89岁20%,≥90岁14%。
- 与较高生存率相关的因素:初始可电击心律、院内心搏骤停发生在心电图监测地点、目击、白天(8 a.m.—8 p.m.)发生、心律失常病因。
- 与较低生存率相关的因素:心力衰竭病史、呼吸功能不全、肾功能不全、急性肺水肿病因。
- ≥90岁且初始心律为VF/VT的患者生存率为41%。
- 随年龄增加观察到治疗强度降低的趋势(插管更少、肾上腺素和抗心律失常药物使用更少),但年龄与开始心肺复苏的延迟无关联。
- 存活者中年龄与良好神经功能结局(CPC 1—2)无显著关联:70—79岁92%、80—89岁93%、≥90岁88%。
证据类型、等级与局限
- 证据类型:大型观察性研究,基于瑞典心肺复苏登记2007—2015年数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,某些亚组相对较高的生存率提示关于预立医疗指示的讨论应个体化。
- 大多数存活者神经功能结局良好,即使90岁以上患者亦然。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There have been few studies of the outcome in elderly patients who have suffered in-hospital cardiac arrest (IHCA) and the association between cardiac arrest characteristics and survival.
AIM: The aim of this large observational study was to investigate the survival and neurological outcome in the elderly after IHCA, and to identify which factors were associated with survival.
METHODS: We investigated elderly IHCA patients (≥70years of age) who were registered in the Swedish Cardiopulmonary Resuscitation Registry 2007-2015. For descriptive purposes, the patients were grouped according to age (70-79, 80-89, and ≥90years). Predictors of 30-day survival were identified using multivariable analysis.
RESULTS: Altogether, 11,396 patients were included in the study. Thirty-day survival was 28% for patients aged 70-79 years, 20% for patients aged 80-89 years, and 14% for patients aged ≥90years. Factors associated with higher survival were: patients with an initially shockable rhythm, IHCA at an ECG-monitored location, IHCA was witnessed, IHCA during daytime (8 a.m.-8 p.m.), and an etiology of arrhythmia. A lower survival was associated with a history of heart failure, respiratory insufficiency, renal dysfunction and with an etiology of acute pulmonary oedema. Patients over 90 years of age with VF/VT as initial rhythm had a 41% survival rate. We found a trend indicating a less aggressive care with increasing age during cardiac arrest (fewer intubations, and less use of adrenalin and anti-arrhythmic drugs) but there was no association between age and delay in starting cardiopulmonary resuscitation (CPR). In survivors, there was no significant association between age and a favourable neurological outcome (CPC score: 1-2) (92%, 93%, and 88% in the three age groups, respectively).
CONCLUSIONS: Increasing age among the elderly is associated with a lower 30-day survival after IHCA. Less aggressive treatment and a worse risk profile might contribute to these findings. Relatively high survival rates among certain subgroups suggest that discussions about advanced directives should be individualized. Most survivors have good neurological outcome, even patients over 90 years of age.
参考来源
- Hirlekar G, Karlsson T, Aune S, et al. Survival and neurological outcome in the elderly after in-hospital cardiac arrest. Resuscitation. 2017. PMID: 28736324. doi:10.1016/j.resuscitation.2017.07.013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。